Tuesday, 9 December 2014

Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis

The cumulative use of pioglitazone or rosiglitazone was not associated with the incidence of bladder cancer in this large, pooled multipopulation analysis (Diabetologia)

No comments:

Post a Comment